ANALYSIS OF EFFECTIVENESS CRITERIA IN PHARMACOECONOMIC STUDIES OF ANTIMICROBIAL THERAPEUTIC AGENTS PROPOSED FOR INCLUSION IN THE ESSENTIAL DRUG LIST (RUSSIA) IN 2014-2016.

Author(s)

Kolbin A, Gomon Y
Pavlov Medical University, St.Petersburg, Russian Federation

Presentation Documents

OBJECTIVES:  To determine the proportion of hard and surrogate endpoints chosen as effectiveness criteria in pharmacoeconomic studies of antimicrobial therapeutic agents proposed for inclusion in the essential drug lists (Russia) in 2014-2016. METHODS:  Analysis of pharmacoeconomic studies included in 30 antimicrobial pharmaceutical agents dossier proposed for inclusion in the essential drug list (Russia) in 2014-2016.  RESULTS:

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PRM8

Topic

Clinical Outcomes

Topic Subcategory

Clinical Outcomes Assessment

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×